The comparison of the average SOD1, SOD2, and SOD3 mRNA synthesis in normal and PTC showed 4.6% (SD 4.9), 3.5% (SD 17.1), and 18.6% (SD 13.1) decreased expression in cancer, respectively (Fig. 10). The gene discussed is SOD1; the disease is cancer.